Skip to Main Content

On the surface, a pregnant woman and a person with cancer would seem to have little in common. But both may have DNA that isn’t the sequence they were born with floating around in their blood.

That DNA — from a fetus or a cancer — provides a potential target for new, non-invasive tests. Some researchers and companies are leveraging expertise in either circulating tumor DNA or non-invasive prenatal testing to develop tests in the other field.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!